Article
The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans.
The Journal of clinical investigation - 1 Aug 2011
Weissglas-Volkov Daphna, Calkin Anna C, Tusie-Luna Teresa, Sinsheimer Janet S, Zelcer Noam, Riba Laura, Tino Ana Maria Vargas, Ordoñez-Sánchez Maria Luisa, Cruz-Bautista Ivette, Aguilar-Salinas Carlos A, Tontonoz Peter, Pajukanta Päivi
Abstract excerpt
Atherosclerotic cardiovascular disease (ASCVD) affects more than 1 in 3 American adults. Hypercholesterolemia is a major treatable risk factor for ASCVD, yet many individuals fail to reach target levels of LDL-cholesterol (LDL-C) through the use of statins and lifestyle changes. The E3 ubiquitin ligase myosin regulatory light chain-interacting protein (MYLIP; also known as IDOL) is a recently identified regulator...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
